Scholarlink

Purpose of Review <p>This review aims to provide a summary of intensive care management and liver transplant (LT) considerations for critically ill patients with cirrhosis and acute-on-chronic liver failure (ACLF).</p> Recent Findings <p>Survival rates for transplanted ACLF patients now approach those of non-ACLF LT recipients. However, candidate selection remains challenging, with high rates of waitlist removal and mortality.</p> Summary <p>Currently, LT is the only effective treatment for patients with ACLF, conferring significant survival benefits and increased resource utilization. High-grade ACLF, defined by the dynamic assessment of associated organ failures at days 3–7, is the most reliable prognostic indicator in ACLF. Liver-specific scores, like the Model for End-Stage Liver Disease, underestimate ACLF mortality, disadvantaging these patients on the waitlist. Improved ICU management of ACLF patients and early LT are associated with improved patient outcomes. Ongoing efforts to develop scoring systems and policies that improve access to LT for ACLF patients are underway.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

From Critical Care to Transplant: Enhancing Outcomes in Acute-on-Chronic Liver Failure

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年3月6日

查看全文
  • Mahnur Haider,
  • Indira Bhavsar-Burke,
  • Christina C. Lindenmeyer

摘要

Purpose of Review

This review aims to provide a summary of intensive care management and liver transplant (LT) considerations for critically ill patients with cirrhosis and acute-on-chronic liver failure (ACLF).

Recent Findings

Survival rates for transplanted ACLF patients now approach those of non-ACLF LT recipients. However, candidate selection remains challenging, with high rates of waitlist removal and mortality.

Summary

Currently, LT is the only effective treatment for patients with ACLF, conferring significant survival benefits and increased resource utilization. High-grade ACLF, defined by the dynamic assessment of associated organ failures at days 3–7, is the most reliable prognostic indicator in ACLF. Liver-specific scores, like the Model for End-Stage Liver Disease, underestimate ACLF mortality, disadvantaging these patients on the waitlist. Improved ICU management of ACLF patients and early LT are associated with improved patient outcomes. Ongoing efforts to develop scoring systems and policies that improve access to LT for ACLF patients are underway.